Related references
Note: Only part of the references are listed.Protective Effect of Statins on Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients: A Nationwide Retrospective, Matched Cohort Study
Wen-Ting Wu et al.
SCIENTIFIC REPORTS (2020)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease A Nested Case-Control Study
Meng-Ting Wang et al.
JAMA INTERNAL MEDICINE (2018)
Statin use and risk of contralateral breast cancer: a nationwide cohort study
Rikke Langballe et al.
BRITISH JOURNAL OF CANCER (2018)
The Effects of Statins on Pulmonary Artery Pressure in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
Anahita Arian et al.
JOURNAL OF RESEARCH IN PHARMACY PRACTICE (2017)
A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension
Bharti Chogtu et al.
INDIAN JOURNAL OF PHARMACOLOGY (2016)
Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study
Ju-Chi Liu et al.
ONCOTARGET (2016)
Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study
Ju-Chi Liu et al.
ONCOTARGET (2016)
Prognostic Factors in Patients With Pulmonary Hypertension-A Nationwide Cohort Study
Wei-Ting Chang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Clinical characteristics and risk factors of pulmonary hypertension associated with chronic respiratory diseases: a retrospective study
Yonghua Chen et al.
Journal of Thoracic Disease (2016)
Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Pulmonary Fibrosis: Prevalence and Hemodynamic Differences in Lung Transplant Recipients at Transplant Center's Referral Time
P. Solidoro et al.
TRANSPLANTATION PROCEEDINGS (2015)
Pulmonary hypertension in COPD: results from the ASPIRE registry
Judith Hurdman et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Evaluation of the Effects of Atorvastatin on the Treatment of Secondary Pulmonary Hypertension due to Chronic Obstructive Pulmonary Diseases: A Randomized Controlled Trial
Seyed Ali Javad Moosavi et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2013)
Atorvastatin in Pulmonary Arterial Hypertension (APATH) study
Wei-Jie Zeng et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Statin Rebound or Withdrawal Syndrome: Does It Exist?
Andres Pineda et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Simvastatin as a Treatment for Pulmonary Hypertension Trial
Martin R. Wilkins et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension
Tsung-Ming Lee et al.
CLINICAL SCIENCE (2009)
Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats
Xiaowei Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Fluvastatin Treatment and Withdrawal: Effects on Endothelial Function
Sabine Westphal et al.
ANGIOLOGY (2008)
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
V Cottin et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
The lipid and non-lipid effects of statins
AS Wierzbicki et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Share Paper
